Articles, guides, and regulatory updates from our community.
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
New research links mitochondrial dysfunction and oxidative stress to gestational diabetes, placental problems, and offspring metabolic risk. Learn what the science shows.
By Peptide Association Research Team
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy. Learn what the study found.
By Peptide Association Research Team
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 may protect against heart damage from chemotherapy drugs through H2O2 regulation mechanisms.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 could help prevent heart damage from cancer treatment. Learn about this promising research.
By Peptide Association Research Team
Recent 2026 study shows SS-31 peptide in targeted liposomes may improve mitochondrial function in fat cells. Animal research suggests potential for obesity treatment.
By Peptide Association Research Team
New research explores how the mitochondria-targeted antioxidant peptide SS-31 may help protect cardiac function in laboratory studies of doxorubicin toxicity.
By Peptide Association Research Team